Oric Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,066 | $0 |
Gross Profit | -310 | -302 | 533 | -270 |
EBITDA | -39,064 | -32,718 | -39,266 | -38,048 |
EBIT | -33,020 | -39,570 | -38,318 | |
Net Income | -36,355 | -30,021 | -36,307 | -34,566 |
Net Change In Cash | 0 | 0 | 1,066 | 0 |
Free Cash Flow | -30,842 | -32,533 | -28,273 | -29,215 |
Cash | 75,864 | 49,334 | 59,406 | 44,230 |
Basic Shares | 78,126 | 71,040 | 70,652 | 70,542 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,107 | -1,032 | -966 | -897 |
EBITDA | -126,740 | -109,748 | -88,156 | -77,974 |
EBIT | -127,847 | -110,780 | -89,122 | -78,871 |
Net Income | -127,847 | -100,697 | -89,122 | -77,677 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -159,166 | 148,028 | ||
Free Cash Flow | -113,850 | -86,537 | -77,221 | -60,480 |
Cash | 59,406 | 23,384 | 66,840 | 226,006 |
Basic Shares | 69,727 | 51,450 | 39,655 | 37,954 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.47 |
2025-03-31 | -$0.42 |
2024-12-31 | -$0.51 |
